free trade agreement between the efta states and the republic of serbia

- 18 -HS HeadingDescription of ProductWorking or Processing, Carried out on Non-Originating Materials,Which Confers Originating Status(1) (2) (3) or (4)ex 2932- Internal ethers and theirhalogenated, sulphonated,nitrated or nitrosatedderivativesManufacture from materials ofany heading. However, thevalue of all the materials ofheading 2909 used shall notexceed 20 % of the ex-worksprice of the productManufacture in which the valueof all the materials used does notexceed 40 % of the ex-worksprice of the product- Cyclic acetals and internalhemiacetals and theirhalogenated, sulphonated,nitrated or nitrosatedderivativesManufacture from materials ofany headingManufacture in which the valueof all the materials used does notexceed 40 % of the ex-worksprice of the product2933 Heterocyclic compounds withnitrogen hetero-atom(s) only2934 Nucleic acids and their salts,whether or not chemicallydefined; other heterocycliccompoundsManufacture from materials ofany heading. However, thevalue of all the materials ofheadings 2932 and 2933 usedshall not exceed 20 % of theex-works price of the productManufacture from materials ofany heading. However, thevalue of all the materials ofheadings 2932, 2933 and 2934used shall not exceed 20 % ofthe ex-works price of theproductManufacture in which the valueof all the materials used does notexceed 40 % of the ex-worksprice of the productManufacture in which the valueof all the materials used does notexceed 40 % of the ex-worksprice of the productex 2939ex Chapter 30Concentrates of poppy strawcontaining not less than 50 %by weight of alkaloidsPharmaceutical products;except for:Manufacture in which thevalue of all the materials useddoes not exceed 50 % of theex-works price of the productManufacture from materials ofany heading, except that of theproduct. However, materials ofthe same heading as theproduct may be used, providedthat their total value does notexceed 20 % of the ex-worksprice of the product3002 Human blood; animal bloodprepared for therapeutic,prophylactic or diagnostic uses;antisera and other bloodfractions and modifiedimmunological products,whether or not obtained bymeans of biotechnologicalprocesses; vaccines, toxins,cultures of micro-organisms(excluding yeasts) and similarproducts: